MAPT and Alzheimer disease: This study delves into the intricate interplay between the AD pathological biomarkers, focusing on ApoE4 status in correlation with p-tau (AT8) and Aβ (6e10), Hematoxylin-stained nuclei, NeuN, Iba1 and GFAP glia cell activation.